This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
A comprehensive resequence analysis of the KLK15–KLK3–KLK2 locus on chromosome 19q13.33
Human Genetics Open Access 13 October 2009
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Eeles, R.A. et al. Nat. Genet. 40, 316–321 (2008).
Ahn, J. et al. Nat. Genet. 40, 1032–1036 (2008).
Kote-Jarai, Z. et al. Cancer Epidemiol. Biomarkers Prev. (in the press).
Thompson, I.M. et al. J. Clin. Oncol. 25, 3076–3081 (2007).
Lai, J. et al. Carcinogenesis 28, 1032–1039 (2007).
Lilja, H. et al. J. Clin. Oncol. 25, 431–436 (2007).
Acknowledgements
This work was supported by Cancer Research UK Grant C5047/A3354. D.F.E. is a Principal Research Fellow of Cancer Research UK. We would also like to thank the following for funding support: The Institute of Cancer Research and The Everyman Campaign, The Prostate Cancer Research Foundation, Prostate Research Campaign UK, The National Cancer Research Network UK, The National Cancer Research Institute (NCRI) UK, grants from the National Health and Medical Research Council, Australia (209057, 251533, 450104), VicHealth, The Cancer Council Victoria, The Whitten Foundation and Tattersall's. The ProtecT study is ongoing and is funded by the Health Technology Assessment Programme (projects 96/20/06, 96/20/99). The ProtecT trial and its linked ProMPT and CAP (Comparison Arm for ProtecT) studies are supported by Department of Health, England, Cancer Research UK grant number C522/A8649, Medical Research Council of England grant number G0500966, ID 75466 and The NCRI, UK. The epidemiological data for ProtecT were generated though funding from the Southwest National Health Service Research and Development. The views and opinions expressed herein are those of the authors and do not necessarily reflect those of the Department of Health of England.
Author information
Authors and Affiliations
Consortia
Ethics declarations
Competing interests
S. Machtens, a member of PRACTICAL, has received Bard, Pfizer, Sanofi–Aventis Speakers Bureau/Honoraria. R. Eeles has received educational grants from Tepnel Life Sciences and Illumina. In our opinion this does not influence the content of the paper.
Additional information
A full list of authors is provided in the Supplementary Note.
Supplementary information
Supplementary Information
Supplementary Note (PDF 67 kb)
Rights and permissions
About this article
Cite this article
Eeles, R., Giles, G., Neal, D. et al. Reply to “Variation in KLK genes, prostate-specific antigen and risk of prostate cancer”. Nat Genet 40, 1035–1036 (2008). https://doi.org/10.1038/ng0908-1035
Issue Date:
DOI: https://doi.org/10.1038/ng0908-1035
This article is cited by
-
A comprehensive resequence analysis of the KLK15–KLK3–KLK2 locus on chromosome 19q13.33
Human Genetics (2010)
-
Identification of new genetic risk factors for prostate cancer
Asian Journal of Andrology (2009)
-
Identification of seven new prostate cancer susceptibility loci through a genome-wide association study
Nature Genetics (2009)